ECO Animal Health to host two Capital Markets events

ECO Animal Health Group plc (LON:EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, has announced that it will be hosting two Capital Markets events focused on progress and developments in the Company’s Research & Development portfolio today, Thursday 9 November 2023.

No new material information will be disclosed at the events.

ECO Animal Health Group plc researches, develops and commercialises products for livestock.

Share on:

Written by: Amilia Stone

Find more news, interviews, share price & company profile here for:
Eco Animal Health Group plc

Latest Company News

ECO Animal Health disposes of ECOmectin® to ACME for €1.3m

ECO Animal Health Group plc has announced the disposal of ECOmectin® Horsepaste to ACME Drugs S.r.l in Italy, focusing on core species of pigs and poultry.

ECO Animal Health reports strong trading from health products globally

ECO Animal Health Group plc (LON:EAH) updates on trading and business progress, with strong revenue driven by Aivlosin® and R&D investments for future growth.

ECO Animal Health appoints Dr. Joachim Hasenmaier as a Non-Executive Director

ECO Animal Health Group plc has appointed Dr. Joachim Hasenmaier as a Non-Executive Director. With extensive experience in the animal health industry, Dr. Hasenmaier's appointment is expected to drive growth and capitalize on future opportunities.

ECO Animal Health ECOVAXXIN® trademark approved by the EU

ECO Animal Health Group plc has announced that its trademark, ECOVAXXIN®, has been approved by the European Union, providing extensive protection in key markets for animal health products. This trademark will brand a family of vaccine products, supporting the company's strategy of growth through R&D.